What should I Know Regarding Pregnancy, Nursing and Administering Dolutegravir 50 Mg-Lamivudine 300 Mg Tablet to Children or the Elderly?

If you are PREGNANT

  • FDB Contraindicated or Not Recommended: CASE REPORTS OF NEURAL TUBE DEFECTS AFTER EXPOSURE DURING TIME OF CONCEPTION
  • FDB Only When Necessary: NO FDA CAT;ART PREG REGISTRY DATA SHOW NO INCREASED RISK FOR MAJOR BIRTH DEFECTS

If you are NURSING

  • Absolute Contraindication: CDC DOES NOT RECOMMEND BREASTFEEDING IN HIV-POSITIVE WOMEN
  • Absolute Contraindication: AVOID BREASTFEEDING IN HIV POSITIVE WOMEN PER CDC

If you are an adult over 60

Giving Dolutegravir 50 Mg-Lamivudine 300 Mg Tablet to a child under 12

  • management or monitoring precaution: The safety and efficacy have not been established in pediatric patients

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.